News | Digital Pathology | July 16, 2019

Article published in Nature Medicine provides further scientific evidence for deployment of computational decision support systems to improve patient care

Paige Announces Clinical-grade Artificial Intelligence in Pathology

July 16, 2019 — Computational pathology company Paige announced the publication of an article in Nature Medicine describing an artificial intelligence (AI) system for computational pathology that achieves clinical-grade accuracy levels. The paper provides further scientific evidence that pathologists’ work in diagnosing and treating cancer can be complemented and aided through the deployment of computational decision-support systems to improve patient care.

The team of scientists responsible for the work described in the article developed specially-designed deep learning algorithms to build a system that can detect prostate cancer, skin cancer and breast cancer with near-perfect accuracy. These algorithms are based on a vast dataset of nearly 45,000 de-identified, digitized slide images from more than 15,000 cancer patients from 44 countries.

The paper outlines how a series of novel algorithms, created using datasets 10 times larger than those that have been manually curated, performed better and also are more generalizable. The significance of this new development hinges on the fact that curating datasets can be prohibitively expensive and time intensive. By eliminating the need to curate datasets, Paige can now develop many more highly accurate algorithms that can be built into clinical decision support products to help pathologists around the world drive better patient care.

Paige plans to commercialize several of these solutions to address the most pressing needs in pathology to improve patient care. The company has already built on the academic work described in Nature Medicine to develop a clinical product, based on technology currently under review by the U.S. Food and Drug Administration (FDA) as a designated Breakthrough Device, for an intended indication different than the one described in the article.

All data collection, research and analysis for this research was conducted exclusively at Memorial Sloan Kettering (MSK) in New York City. The publication of the study’s findings was the result of collaboration between numerous researchers and clinicians, and made possible by Paige’s partnership with MSK. All data were de-identified and did not contain any protected health information or label text. 

Watch the VIDEO: Integrating Digital Pathology With Radiology

For more information: www.nature.com/nm

Reference

1. Campanella G., Hanna M.G., Geneslaw L., et al. Clinical-grade Computational Pathology using Weakly Supervised Deep Learning on Whole Slide Images. Nature Medicine, July 15, 2019. https://doi.org/10.1038/s41591-019-0508-1

Related Content

News | Digital Pathology

October 18, 2021 — Histolix, a leading developer of direct-to-digital read pathology solutions, announced it has ...

Time October 18, 2021
arrow
News | Artificial Intelligence

October 11, 2021 — The Icahn School of Medicine at Mount Sinai has launched a new department dedicated to advancing ...

Time October 11, 2021
arrow
News | Information Technology

October 6, 2021 — Fujifilm Medical Systems U.S.A., Inc. and Fujifilm Healthcare Americas Corporation (formerly Hitachi ...

Time October 06, 2021
arrow
News | Cardiovascular Ultrasound

October 5, 2021 – UltraSight, a digital health company developing artificial intelligence (AI) enabled cardiac imaging ...

Time October 05, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Breast Imaging

September 28, 2021 — A computer program trained to see patterns among thousands of breast ultrasound images can aid ...

Time September 28, 2021
arrow
News | Artificial Intelligence

September 27, 2021 — Zebra Medical Vision, the deep-learning medical imaging analytics company, announces its eighth U.S ...

Time September 27, 2021
arrow
News | Artificial Intelligence

September 24, 2021 — Owkin, a startup that deploys artificial intelligence (AI) and Federated Learning technologies to ...

Time September 24, 2021
arrow
News | Digital Pathology

September 22, 2021 — The U.S. Food and Drug Administration authorized marketing of software to assist medical ...

Time September 22, 2021
arrow
News | Artificial Intelligence

September 22, 2021 — The RACE AI study conducted by Gustave Roussy and the startup Owkin, as part of the AI for Health ...

Time September 22, 2021
arrow
Subscribe Now